06.10.2015 • News

Clariant to Buy Part of Vivimed Portfolio

Swiss specialty chemicals producer Clariant said it intends to acquire a part of Vivimed Labs’ personal care portfolio.

Clariant said the acquisition of the Indian company will enable its wholly owned subsidiary Clariant India to strengthen its personal care portfolio within the Industrial & Consumer Specialties (ICS) business unit and offer a wider product portfolio within the sun, skin, hair and oral care range as well as anti-microbial preservatives.

“The personal care industry in India offers us immense potential, supported by the growing middle-class consumer population and the rising disposable income,” said Deepak Parikh, Clariant’s region president for India, Middle East and Africa.

Santosh Varalwar, CEO of Vivimed Labs, said the deal with Clariant will “significantly improve” his company’s financial flexibility and position it for further growth across its specialty chemicals and pharmaceuticals businesses.

Interview

Navigating Uncertainty and Driving Innovation
Meeting Pharma’s Demand for Speed, Reliability, and Flexibility

Navigating Uncertainty and Driving Innovation

Axplora CCO Arul Ramadurai discusses navigating industry uncertainty, building strategic partnerships, and advancing flexible pharmaceutical manufacturing

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.